Olof C B Vermeulen, Elisabeth Brouwer, Riemer H J A Slart, Maria Sandovici, Abraham Rutgers, T Jeroen Hilterman, Birgitta Hiddinga, Sjoukje F Oosting, Mathilde Jalving, Albert H de Heij, Daan G Knapen, Geke A P Hospers, Kornelis S M van der Geest
OBJECTIVES: To compare clinical characteristics, imaging findings and treatment requirements of patients with immune checkpoint inhibitor-mediated polymyalgia rheumatica (ICI-PMR) and primary PMR. METHODS: This single centre, retrospective cohort study compared ICI-PMR in patients with cancer (n = 15) to patients with primary PMR (n = 37). A comparison was made between clinical symptoms, laboratory markers, ultrasonography,18F-FDG-PET/CT findings and treatment requirements related to PMR...
February 9, 2024: Rheumatology